Skip to main content

Published locations for Real-world study supports tocilizumab as first-line biologic in DMARD-IR patients with RA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Real-world study supports tocilizumab as first-line biologic in DMARD-IR patients with RA

User login

  • Reset your password
  • /content/real-world-study-supports-tocilizumab-first-line-biologic-dmard-ir-patients-ra
  • /rheumatology/article/265387/rheumatoid-arthritis/real-world-study-supports-tocilizumab-first-line